Yahoo
Toronto - Delayed Quote CAD

Aurora Cannabis Inc. (ACB.TO)

5.57 -0.03 (-0.54%)
At close: September 2 at 4:00:00 PM EDT
Chart Range Bar
Loading chart for ACB.TO
  • Previous Close 5.60
  • Open 5.59
  • Bid 5.57 x --
  • Ask 5.58 x --
  • Day's Range 5.56 - 5.75
  • 52 Week Range 3.59 - 9.33
  • Volume 320,348
  • Avg. Volume 464,419
  • Market Cap (intraday) 352.637M
  • Beta (5Y Monthly) 1.34
  • PE Ratio (TTM) --
  • EPS (TTM) -0.92
  • Earnings Date (est.) Nov 4, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 5.38

Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products. It also provides harvested cannabis, trim, cannabis oils, capsules, edibles, vaporizers, dried and fresh cannabis, cannabis plants, cannabis seeds, edible cannabis, cannabis extracts, flowers, vapes / inhalable extracts, edibles / pastilles, concentrates, and cannabis topicals; and patient counseling and outreach services. Its brand portfolio includes Aurora, Being, CanniMed, CraftPlant, Daily Special, Drift, Greybeard, IndiMed, MedReleaf, Pedanios, San Raf, Tasty's, Whistler, and WMMC. The company also engages in pharmacy activities. Aurora Cannabis Inc. was founded in 2013 and is headquartered in Edmonton, Canada.

www.auroramj.com

1,028

Full Time Employees

March 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 9/2/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

ACB.TO
4.46%
S&P/TSX Composite index (^GSPTSE)
13.26%

1-Year Return

ACB.TO
21.88%
S&P/TSX Composite index (^GSPTSE)
26.13%

3-Year Return

ACB.TO
14.31%
S&P/TSX Composite index (^GSPTSE)
75.67%

5-Year Return

ACB.TO
94.02%
S&P/TSX Composite index (^GSPTSE)
73.56%

Earnings Trends

View More

Earnings Per Share (GAAP)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY27
Revenue 67.55M
Earnings -4.03M
Profit Margin -5.97%

Q2

FY26

Q3

FY26

Q4

FY26

Q1

FY27

-50M
0
50M
-150.0%
-100.0%
-50.0%
0.0%

Analyst Insights

View More

Analyst Price Targets

4.00 Low
5.38 Average
5.57 Current
8.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
As of 8/7/2026
  • Market Cap

    354.54M

  • Enterprise Value

    277.19M

  • Trailing P/E

    --

  • Forward P/E

    108.70

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.04

  • Price/Book (mrq)

    0.67

  • Enterprise Value/Revenue

    0.88

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -38.25%

  • Return on Assets (ttm)

    -3.72%

  • Return on Equity (ttm)

    -9.40%

  • Revenue (ttm)

    314.07M

  • Net Income Avi to Common (ttm)

    -52.47M

  • Diluted EPS (ttm)

    -0.92

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    100.03M

  • Total Debt/Equity (mrq)

    4.30%

  • Levered Free Cash Flow (ttm)

    -20.04M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: